Maximus, Inc. (NYSE:MMS) President Bruce Caswell sold 8,000 shares of the business’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $60.50, for a total value of $484,000.00. Following the transaction, the president now directly owns 35,904 shares of the company’s stock, valued at approximately $2,172,192. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Bruce Caswell also recently made the following trade(s):

  • On Thursday, August 10th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $59.83, for a total value of $478,640.00.
  • On Thursday, July 27th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $60.97, for a total value of $487,760.00.
  • On Wednesday, July 12th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $62.21, for a total value of $497,680.00.
  • On Friday, June 16th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $63.56, for a total value of $508,480.00.
  • On Monday, June 5th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $63.48, for a total value of $507,840.00.
  • On Tuesday, May 23rd, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $62.76, for a total value of $502,080.00.

Shares of Maximus, Inc. (NYSE MMS) traded down 1.82% during midday trading on Thursday, reaching $59.35. The company had a trading volume of 341,607 shares. The company has a 50 day moving average of $61.00 and a 200 day moving average of $60.98. Maximus, Inc. has a one year low of $43.69 and a one year high of $64.97. The company has a market capitalization of $3.85 billion, a PE ratio of 19.02 and a beta of 1.39.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million for the quarter, compared to the consensus estimate of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.79 earnings per share. Analysts predict that Maximus, Inc. will post $3.12 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th will be issued a $0.045 dividend. The ex-dividend date is Friday, August 11th. This represents a $0.18 annualized dividend and a dividend yield of 0.30%. Maximus’s dividend payout ratio is currently 5.73%.

COPYRIGHT VIOLATION WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/08/17/maximus-inc-mms-president-sells-484000-00-in-stock.html.

A number of brokerages recently weighed in on MMS. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Maxim Group set a $66.00 price objective on Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. BidaskClub lowered Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Canaccord Genuity lowered Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a research report on Tuesday, July 4th. Finally, KeyCorp restated a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. One investment analyst has rated the stock with a sell rating and eight have issued a hold rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $62.17.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of Montreal Can boosted its stake in Maximus by 56.5% in the first quarter. Bank of Montreal Can now owns 125,084 shares of the health services provider’s stock valued at $7,780,000 after buying an additional 45,167 shares during the last quarter. Capstone Asset Management Co. boosted its stake in Maximus by 3.0% in the first quarter. Capstone Asset Management Co. now owns 6,972 shares of the health services provider’s stock valued at $434,000 after buying an additional 200 shares during the last quarter. Louisiana State Employees Retirement System boosted its stake in Maximus by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the health services provider’s stock valued at $1,020,000 after buying an additional 400 shares during the last quarter. Cim LLC acquired a new stake in Maximus during the first quarter valued at about $504,000. Finally, Alta Capital Management LLC boosted its stake in Maximus by 2.9% in the first quarter. Alta Capital Management LLC now owns 640,174 shares of the health services provider’s stock valued at $39,818,000 after buying an additional 17,950 shares during the last quarter. Hedge funds and other institutional investors own 97.20% of the company’s stock.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.